Report Company Directory

INNVENTURE INC

• Innventure Reports Second Quarter 2025 Results by GlobeNewsWire
• Innventure, Inc. to Announce Second Quarter 2025 Results on August 14, 2025 by GlobeNewsWire
• Accelsius Demonstrates Strong Momentum in First Half of 2025 with 5x Growth in Data Center Deployments by GlobeNewsWire
• Accelsius Brings NeuCool™ to Equinix’s Co-Innovation Facility in Ashburn by GlobeNewsWire
• Accelsius Strengthens Presence in European Data Centers with Global Switch Collaboration and London Showcase by GlobeNewsWire
• Innventure to Participate in Upcoming Investor Conferences by GlobeNewsWire
• Accelsius Joins ARPA-E COOLERCHIPS Project to Advance Hybrid Cooling Technologies for the Data Center of the Future by GlobeNewsWire
• Innventure Reports First Quarter 2025 Results by GlobeNewsWire
• Innventure, Inc. to Announce First Quarter 2025 Results on May 15, 2025 by GlobeNewsWire
• Innventure to Present at Upcoming Innovation Conferences by GlobeNewsWire

InnVest Real Estate Investment Trust

• Monthly LMI Update Independent Investment Research by Independent Investment Research

Inogen Inc.

• Dropping Coverage of Three Medical Technology Companies (STIM, INGN, SKIN) by William Blair
• Today at 10 a.m. ET: Growth Stock Conference 2025 Recap Call by William Blair
• Growth Stock Conference 2025 Recap Call: June 6 at 10 a.m. ET by William Blair
• Growth Stock Conference 2025 Recap Call: June 6 at 10 a.m. ET by William Blair
• Growth Stock Conference 2025 Recap Call: June 6 at 10 a.m. ET by William Blair
• Another Solid Beat on B2B Demand by William Blair
• Equity Research Rewind: Inaugural Edition by William Blair
• Initial Stock Ideas for Worsening Macro and Inflation Headwinds by William Blair
• Special Report on Liberation Day Tariff Announcements by William Blair
• Inogen To Present at 24th Annual Needham Virtual Healthcare Conference by BusinessWire

INOLIFE TECHNOLOGIES INC

Inotek Pharmaceuticals Corp

• Inotek Pharmaceuticals Announces Filing of Preliminary Proxy Statement for Proposed Merger with Clinical-stage Gene Therapy Company, Rocket Pharmaceuticals by BusinessWire
• INSERTING and REPLACING Inotek Pharmaceuticals Announces Merger Agreement with Rocket Pharmaceuticals to Advance Pipeline of First-in-Class Gene Therapies for Rare Diseases by BusinessWire
• Inotek Pharmaceuticals Corporation Reports Second Quarter 2017 Financial Results and Operational Highlights by BusinessWire
• Inotek Pharmaceuticals Announces Top-line Results of Phase 2 Fixed-dose Combination Trial of Trabodenoson and Provides Corporate Update by BusinessWire
• Inotek Pharmaceuticals Corporation Reports First Quarter 2017 Financial Results and Operational Highlights by BusinessWire
• Inotek Pharmaceuticals Presents Preclinical Data on Trabodenoson at the Association for Research in Vision and Ophthalmology (ARVO) 2017 Annual Meeting by BusinessWire
• Inotek Completes Patient Recruitment in Phase 2 Trial of a Fixed-dose Combination (FDC) of Trabodenoson and Latanoprost by BusinessWire
• Inotek Pharmaceuticals Corporation Reports Fiscal Year 2016 Financial Results and Operational Highlights by BusinessWire
• Inotek Pharmaceuticals Announces Participation at Upcoming Investor Conferences by BusinessWire
• Inotek Pharmaceuticals Announces Poster Presentations on Trabodenoson at the American Glaucoma Society 2017 Annual Meeting by BusinessWire